Hyperactivity Clinical Trials

115 recruitingLast updated: July 25, 2026

There are 115 actively recruiting hyperactivity clinical trials across 30 countries. Studies span Not Applicable, Phase 4, Phase 2, Phase 1, Phase 3. Top locations include Cincinnati, Ohio, United States, Baltimore, Maryland, United States, Hong Kong, Hong Kong. Updated daily from ClinicalTrials.gov.


Hyperactivity Trials at a Glance

115 actively recruiting trials for hyperactivity are listed on ClinicalTrialsFinder across 6 cities in 30 countries. The largest study group is Not Applicable with 62 trials, with the heaviest enrollment activity in Cincinnati, Baltimore, and Hong Kong. Lead sponsors running hyperactivity studies include Chinese University of Hong Kong, Otsuka Pharmaceutical Co., Ltd., and Duke University.

Browse hyperactivity trials by phase

Treatments under study

About Hyperactivity Clinical Trials

Looking for clinical trials for Hyperactivity? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hyperactivity trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hyperactivity clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 115 trials

Recruiting
Not Applicable

Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure

Attention Deficit Hyperactivity DisorderFetal Alcohol Spectrum Disorders
University of California, Los Angeles30 enrolled1 locationNCT06847165
Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Heart FailurePainInsomnia+22 more
Duke University5,000 enrolled51 locationsNCT04278404
Recruiting
Phase 1Phase 2

Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial

Attention Deficit Hyperactivity Disorder
National Institute of Mental Health (NIMH)219 enrolled1 locationNCT05608434
Recruiting
Not Applicable

Effects of Probiotics on the Gut-brain Axis in Children

Attention Deficit Hyperactivity Disorder (ADHD)
Probi AB80 enrolled1 locationNCT07459699
Recruiting
Phase 1

Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease

Cognitive ImpairmentSickle Cell DiseaseAttention Deficit Hyperactivity Disorder (ADHD)+1 more
St. Jude Children's Research Hospital72 enrolled1 locationNCT07226219
Recruiting
Not Applicable

Smartphone-based Intervention for Young Adults With ADHD

Attention Deficit Hyperactivity Disorder (ADHD)Alcohol Use
Traci Kennedy70 enrolled1 locationNCT07654205
Recruiting
Not Applicable

Enhancing Team Effectiveness for a Collaborative School-based Intervention for ADHD

Attention Deficit Hyperactivity DisorderTeam-effectiveness ResearchSchool-based Interventions+1 more
University of California, San Diego144 enrolled1 locationNCT06180681
Recruiting

Developing Brain, Impulsivity and Compulsivity

Autism Spectrum DisorderAttention Deficit Hyperactivity DisorderObsessive-Compulsive Disorder+2 more
National Institute of Mental Health (NIMH)1,100 enrolled1 locationNCT04631042
Recruiting
Not Applicable

Effectiveness of Neuroplasticity-Targeted Supplements on Neuroinflammatory Markers, ADHD Symptom Severity, and Clinical Scores in Children

Attention Deficit Hyperactivity Disorder
Khyber Medical University Peshawar68 enrolled1 locationNCT07665658
Recruiting
Not Applicable

Acupuncture for ADHD: Acupoint Data Mining, Clinical Effectiveness, and Interviews to Explore Treatment Outcomes.

Executive functioningQuality of Life (QOL)ADHD - Attention Deficit Disorder With Hyperactivity+3 more
The Third Affiliated Hospital of Beijing University of Chinese Medicine120 enrolled1 locationNCT06860763
Recruiting
Not Applicable

Effects of Transcranial Photobiomodulation in ADHD

Attention Deficit Hyperactivity Disorder
Francisco Gonzalez-Lima, PhD140 enrolled1 locationNCT07203092
Recruiting
Not Applicable

Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation

Attention Deficit Hyperactivity DisorderAttention DifficultiesCognitive Deficit+2 more
Francisco Gonzalez-Lima, PhD500 enrolled1 locationNCT05802680
Recruiting
Phase 1

A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity DisorderBorderline Personality Disorder
Boehringer Ingelheim68 enrolled7 locationsNCT07001475
Recruiting
Not Applicable

Evaluating Effects of Group-based CBT for Emotion Regulation in Adult ADHD

Attention Deficit Disorder With or Without Hyperactivity (ADHD)
Karolinska Institutet150 enrolled1 locationNCT07614867
Recruiting
Not Applicable

Fronto-Parietal Transcranial Alternating Current Stimulation for ADHD in Children and Adolescents

Attention Deficit Hyperactivity Disorder
Central South University50 enrolled1 locationNCT07633275
Recruiting

Evaluation of the Relationship Between Medication, Eye Movements, and Autonomic Nervous System (ANS) Functions in Children and Adolescents With ADHD

ADHD - Attention Deficit Disorder With Hyperactivity
Umeå University150 enrolled1 locationNCT07634809
Recruiting
Not Applicable

Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder
University of Wisconsin, Madison145 enrolled1 locationNCT02688959
Recruiting
Phase 2

The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder
University of Arkansas, Fayetteville76 enrolled1 locationNCT06115603
Recruiting
Phase 4

Medication Treatment of ADHD in Pediatric Epilepsy

ADHD - Attention Deficit Disorder With Hyperactivity
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.25 enrolled1 locationNCT07594652
Recruiting
Phase 4

Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder Combined
Donald Gilbert, MD, MS, FAAN, FAAP214 enrolled2 locationsNCT04421248